The ability to interact with cell membranes suggests possible biological roles for free light chain

Immunology Letters

Volumn 142, Issue 1-2, 2012, Pages 75-77

  Hutchinson, Andrew T ^a,b   Jones, Darren R ^b   Raison, Robert L ^b  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Free light chain; Immunoglobulin

Indexed keywords

FREE LIGHT CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; SPHINGOMYELIN; UNCLASSIFIED DRUG;

ANTIGEN BINDING; BINDING AFFINITY; CELL LINEAGE; CELL MEMBRANE; CELL TYPE; IMMUNOGLOBULIN STRUCTURE; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LIPID INTERACTION;

ANIMALS; B-LYMPHOCYTES; CELL LINE; CELL LINE, TUMOR; CELL MEMBRANE; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; KIDNEY; KILLER CELLS, NATURAL; LYMPHOCYTES; MICE; MONOCYTES; SPHINGOMYELINS; T-LYMPHOCYTES;

EID: 84857190024     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2011.10.013     Document Type: Letter

References (19)

1. Hopper J.E., Papagiannes E. Evidence by radioimmunoassay that mitogen-activated human blood mononuclear cells secrete significant amounts of light chain Ig unassociated with heavy chain. Cell Immunol 1986, 101:122-131.
2. Bradwell A.R., Mead G.P., Carr-Smith H.D. Serum free light chain analysis 2008, The Binding Site, Birmingham, UK.
3. Laurenzi M.A., Mavra M., Kam-Hansen S., Link H. Oligoclonal IgG and free light chains in multiple sclerosis demonstrated by thin-layer polyacrylamide gel isoelectric focusing and immunofixation. Ann Neurol 1980, 8:241-247.
4. Sølling K., Sølling J., Rømer F.K. Free light chains of immunoglobulins in serum from patients with rheumatoid arthritis, sarcoidosis, chronic infections and pulmonary cancer. Acta Med Scand 1981, 209:473-477.
5. Rudick R.A., Peter D.R., Bidlack J.M., Knutson D.W. Multiple sclerosis: free light chains in cerebrospinal fluid. Neurology 1985, 35:1443-1449.
6. Bradwell A.R., Carr-Smith H.D., Mead G.P., Tang L.X., Showell P.J., Drayson M.T., et al. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 2001, 47:673-680.
7. Hutchinson A.T., Ramsland P.A., Jones D.R., Agostino M., Lund M.L., Jennings C.V., et al. Free immunoglobulin light chains interact with sphingomyelin and are found on the surface of myeloma plasma cells in an aggregated form. J Immunol 2010, 185:4179-4188.
8. Ramirez-Alvarado M., De Stigter J.K., Baden E.M., Sikkink L.A., McLaughlin R.W., Taboas A.L. Immunoglobulin light chain and systemic light-chain amyloidosis. Protein reviews: protein misfolding, aggregation, and conformational diseases 2007, 183-197. Springer. V.N. Uversky, A.L. Fink (Eds.).
9. Sun M., Li L., Gao Q.S., Paul S. Antigen recognition by an antibody light chain. J Biol Chem 1994, 269:734-738.
10. Masat L., Wabl M., Johnson J.P. A simpler sort of antibody. Proc Natl Acad Sci USA 1994, 91:893-896.
11. Ledbetter J.A., Fell H.P., Grosmaire L.S., Norris N.A., Tsu T.T. An immunoglobulin light chain dimer with CD4 antigen specificity. Mol Immunol 1987, 24:1255-1261.
12. Edmundson A.B., Ely K.R., Girling R.L., Abola E.E., Schiffer M., Westholm F.A., et al. Binding of 2,4-dinitrophenyl compounds and other small molecules to a crystalline lambda-type Bence-Jones dimer. Biochemistry 1974, 13:3816-3827.
13. Contini C., Fainardi E., Cultrera R., Seraceni S., Castellazzi M., Peyron F., et al. Evidence of cerebrospinal fluid free kappa light chains in AIDS patients with Toxoplasma gondii encephalitis. J Neuroimmunol 2000, 108:221-226.
14. Redegeld F.A., van der Heijden M.W., Kool M., Heijdra B.M., Garssen J., Kraneveld A.D., et al. Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses. Nat Med 2002, 8:694-701.
15. Groot Kormelink T., Thio M., Blokhuis B.R., Nijkamp F.P., Redegeld F.A. Atopic and non-atopic allergic disorders: current insights into the possible involvement of free immunoglobulin light chains. Clin Exp Allergy 2009, 39:33-42.
16. van der Heijden M., Kraneveld A., Redegeld F. Free immunoglobulin light chains as target in the treatment of chronic inflammatory diseases. Eur J Pharmacol 2006, 533:319-326.
17. Matsumori A., Shimada M., Jie X., Higuchi H., Kormelink T., Redegeld F. Effects of free immunoglobulin light chains on viral myocarditis. Circ Res 2010, 106:1533-1540.
18. Rawat S., Viard M., Gallo S., Rein A., Blumenthal R., Puri A. Modulation of entry of enveloped viruses by cholesterol and sphingolipids. Mol Membr Biol 2003, 20:243-254. [review].
19. Aizaki H., Morikawa K., Fukasawa M., Hara H., Inoue Y., Tani H., et al. Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection. J Virol 2008, 82:5715-5724.